Your browser doesn't support javascript.
loading
Efficacy of colchicine in patients with moderate COVID-19: A double-blinded, randomized, placebo-controlled trial.
Rahman, Motlabur; Datta, Ponkaj K; Islam, Khairul; Haque, Mahfuzul; Mahmud, Reaz; Mallik, Uzzwal; Hasan, Pratyay; Haque, Manjurul; Faruq, Imtiaz; Sharif, Mohiuddin; Ratul, Rifat H; Azad, Khan Abul Kalam; Miah, Titu; Rahman, Md Mujibur.
Afiliación
  • Rahman M; Department of Medicine, Dhaka Medical College, Dhaka, Bangladesh.
  • Datta PK; Department of Medicine, Dhaka Medical College, Dhaka, Bangladesh.
  • Islam K; Department of Medicine, Dhaka Medical College, Dhaka, Bangladesh.
  • Haque M; Department of Medicine, Dhaka Medical College, Dhaka, Bangladesh.
  • Mahmud R; Department of Neurology, Dhaka Medical College, Dhaka, Bangladesh.
  • Mallik U; Department of Medicine, Dhaka Medical College, Dhaka, Bangladesh.
  • Hasan P; Department of Medicine, Dhaka Medical College, Dhaka, Bangladesh.
  • Haque M; Department of Medicine, Dhaka Medical College, Dhaka, Bangladesh.
  • Faruq I; Department of Medicine, Dhaka Medical College, Dhaka, Bangladesh.
  • Sharif M; Department of Medicine, Dhaka Medical College, Dhaka, Bangladesh.
  • Ratul RH; Department of Medicine, Dhaka Medical College, Dhaka, Bangladesh.
  • Azad KAK; Department of Medicine, Dhaka Medical College, Dhaka, Bangladesh.
  • Miah T; Department of Medicine and Principal, Dhaka Medical College, Dhaka, Bangladesh.
  • Rahman MM; Department of Medicine, Dhaka Medical College, Dhaka, Bangladesh.
PLoS One ; 17(11): e0277790, 2022.
Article en En | MEDLINE | ID: mdl-36383611

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Síndrome de Dificultad Respiratoria / Deterioro Clínico / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Guideline Límite: Humans País/Región como asunto: Asia Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Bangladesh

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Síndrome de Dificultad Respiratoria / Deterioro Clínico / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Guideline Límite: Humans País/Región como asunto: Asia Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Bangladesh